Neogen PE Ratio 2010-2024 | NEOG
Current and historical p/e ratio for Neogen (NEOG) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Neogen PE ratio as of November 22, 2024 is 37.45.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Neogen PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-11-21 | 14.58 | 0.00 | |
| 2024-08-31 | 17.25 | $-0.11 | 0.00 |
| 2024-05-31 | 13.15 | $-0.04 | 0.00 |
| 2024-02-29 | 17.19 | $0.01 | 1719.00 |
| 2023-11-30 | 16.97 | $0.06 | 282.83 |
| 2023-08-31 | 23.12 | $-0.11 | 0.00 |
| 2023-05-31 | 17.49 | $-0.07 | 0.00 |
| 2023-02-28 | 17.69 | $0.04 | 442.25 |
| 2022-11-30 | 16.56 | $0.05 | 331.20 |
| 2022-08-31 | 20.90 | $0.34 | 61.47 |
| 2022-05-31 | 26.46 | $0.45 | 58.80 |
| 2022-02-28 | 35.70 | $0.46 | 77.61 |
| 2021-11-30 | 40.13 | $0.54 | 75.01 |
| 2021-08-31 | 43.78 | $0.59 | 74.84 |
| 2021-05-31 | 46.16 | $0.58 | 80.27 |
| 2021-02-28 | 40.96 | $0.58 | 70.62 |
| 2020-11-30 | 37.11 | $0.57 | 65.11 |
| 2020-08-31 | 38.10 | $0.58 | 66.26 |
| 2020-05-31 | 35.61 | $0.57 | 63.03 |
| 2020-02-29 | 30.38 | $0.56 | 54.24 |
| 2019-11-30 | 33.29 | $0.57 | 58.39 |
| 2019-08-31 | 35.26 | $0.57 | 61.86 |
| 2019-05-31 | 28.18 | $0.58 | 49.00 |
| 2019-02-28 | 30.98 | $0.59 | 52.51 |
| 2018-11-30 | 32.43 | $0.63 | 51.89 |
| 2018-08-31 | 46.72 | $0.64 | 73.57 |
| 2018-05-31 | 37.86 | $0.61 | 62.44 |
| 2018-02-28 | 29.14 | $0.56 | 51.91 |
| 2017-11-30 | 31.46 | $0.50 | 62.60 |
| 2017-08-31 | 25.84 | $0.45 | 57.88 |
| 2017-05-31 | 23.73 | $0.43 | 55.50 |
| 2017-02-28 | 24.32 | $0.41 | 60.04 |
| 2016-11-30 | 23.73 | $0.39 | 61.43 |
| 2016-08-31 | 22.15 | $0.37 | 60.27 |
| 2016-05-31 | 18.51 | $0.36 | 50.89 |
| 2016-02-29 | 18.47 | $0.36 | 51.29 |
| 2015-11-30 | 22.15 | $0.35 | 62.81 |
| 2015-08-31 | 19.37 | $0.34 | 56.72 |
| 2015-05-31 | 17.53 | $0.34 | 51.92 |
| 2015-02-28 | 19.18 | $0.32 | 60.17 |
| 2014-11-30 | 16.62 | $0.31 | 53.38 |
| 2014-08-31 | 15.79 | $0.30 | 53.28 |
| 2014-05-31 | 14.17 | $0.29 | 49.50 |
| 2014-02-28 | 16.25 | $0.28 | 57.24 |
| 2013-11-30 | 19.08 | $0.28 | 67.22 |
| 2013-08-31 | 13.53 | $0.29 | 46.64 |
| 2013-05-31 | 13.62 | $0.28 | 48.63 |
| 2013-02-28 | 11.71 | $0.27 | 43.35 |
| 2012-11-30 | 11.39 | $0.26 | 44.22 |
| 2012-08-31 | 9.76 | $0.24 | 40.25 |
| 2012-05-31 | 9.74 | $0.24 | 41.43 |
| 2012-02-29 | 8.68 | $0.24 | 36.91 |
| 2011-11-30 | 8.81 | $0.23 | 37.88 |
| 2011-08-31 | 8.68 | $0.24 | 35.79 |
| 2011-05-31 | 11.21 | $0.24 | 46.23 |
| 2011-02-28 | 9.35 | $0.23 | 40.64 |
| 2010-11-30 | 9.29 | $0.22 | 42.22 |
| 2010-08-31 | 7.31 | $0.21 | 35.63 |
| 2010-05-31 | 6.43 | $0.19 | 33.69 |
| 2010-02-28 | 6.06 | $0.18 | 33.82 |
| 2009-11-30 | 5.42 | $0.17 | 32.22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.246B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.249B | 26.05 |
| Stryker (SYK) | United States | $146.711B | 33.06 |
| Boston Scientific (BSX) | United States | $132.644B | 38.14 |
| EssilorLuxottica (ESLOY) | France | $112.106B | 0.00 |
| Medtronic (MDT) | Ireland | $110.561B | 16.42 |
| Haleon (HLN) | United Kingdom | $43.682B | 28.38 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.166B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.665B | 19.54 |
| ResMed (RMD) | United States | $35.786B | 29.41 |
| Terumo (TRUMY) | Japan | $29.739B | 42.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.805B | 18.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.942B | 13.97 |
| Insulet (PODD) | United States | $18.443B | 73.44 |
| Baxter (BAX) | United States | $16.957B | 11.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.065B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.158B | 40.73 |
| Bio-Rad Laboratories (BIO) | United States | $9.320B | 31.68 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.294B | 14.62 |
| TG Therapeutics (TGTX) | United States | $5.459B | 0.00 |
| Haemonetics (HAE) | United States | $4.297B | 20.97 |
| Prestige Consumer Healthcare (PBH) | United States | $4.192B | 20.85 |
| ICU Medical (ICUI) | United States | $4.125B | 39.27 |
| Perrigo (PRGO) | Ireland | $3.830B | 11.27 |
| Envista Holdings (NVST) | United States | $3.697B | 27.54 |
| Agios Pharmaceuticals (AGIO) | United States | $3.175B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.841B | 18.22 |
| QuidelOrtho (QDEL) | United States | $2.700B | 17.38 |
| LeMaitre Vascular (LMAT) | United States | $2.428B | 59.00 |
| Warby Parker (WRBY) | United States | $2.349B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.913B | 33.48 |
| AtriCure (ATRC) | United States | $1.742B | 0.00 |
| InMode (INMD) | Israel | $1.597B | 9.61 |
| AdaptHealth (AHCO) | United States | $1.326B | 9.48 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.318B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.267B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.207B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.96 |
| Owens & Minor (OMI) | United States | $0.952B | 7.44 |
| CeriBell (CBLL) | United States | $0.943B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.918B | 30.68 |
| Capricor Therapeutics (CAPR) | United States | $0.847B | 0.00 |
| Evolus (EOLS) | United States | $0.798B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.684B | 30.25 |
| Omeros (OMER) | United States | $0.632B | 0.00 |
| Surmodics (SRDX) | United States | $0.563B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.533B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.522B | 0.00 |
| Quanterix (QTRX) | United States | $0.451B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.411B | 0.00 |
| ZimVie (ZIMV) | United States | $0.391B | 32.95 |
| Valneva SE (VALN) | France | $0.360B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.341B | 32.41 |
| Cerus (CERS) | United States | $0.332B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.330B | 0.00 |
| Biote (BTMD) | United States | $0.325B | 7.12 |
| OraSure Technologies (OSUR) | United States | $0.289B | 19.40 |
| Zynex (ZYXI) | United States | $0.263B | 55.07 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.225B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.221B | 15.29 |
| High Tide (HITI) | Canada | $0.213B | 88.33 |
| MacroGenics (MGNX) | United States | $0.203B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Brainsway (BWAY) | Israel | $0.167B | 100.00 |
| Organigram Holdings (OGI) | Canada | $0.166B | 0.00 |
| Jin Medical (ZJYL) | China | $0.164B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.67 |
| TriSalus Life Sciences (TLSI) | United States | $0.138B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 11.74 |
| Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
| Veru (VERU) | United States | $0.099B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.40 |
| Ayr Wellness (AYRWF) | United States | $0.077B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.073B | 37.50 |
| Exagen (XGN) | United States | $0.072B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.062B | 0.00 |
| Modular Medical (MODD) | United States | $0.058B | 0.00 |
| MariMed (MRMD) | United States | $0.057B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Safety Shot (SHOT) | United States | $0.051B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.83 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |